V020-0741 Screening compound: N-[1-(4-fluorophenyl)-4-phenyl-1H-imidazol-2-yl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]acetamide

V020-0741 Screening compound: N-[1-(4-fluorophenyl)-4-phenyl-1H-imidazol-2-yl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]acetamide
V020-0741 Screening compound: N-[1-(4-fluorophenyl)-4-phenyl-1H-imidazol-2-yl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-0741
N-[1-(4-fluorophenyl)-4-phenyl-1H-imidazol-2-yl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-0741

Molecular Formula

C31H32FN5O4 (C31 H32 FN5 O4)

Compound Name

N-[1-(4-fluorophenyl)-4-phenyl-1H-imidazol-2-yl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]acetamide

IUPAC name

N-[1-(4-fluorophenyl)-4-phenyl-1H-imidazol-2-yl]-2-[1-(4-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]acetamide

SMILES

COc(cc1)ccc1C(N(CCN1CCOCC1)CC(Nc1nc(-c2ccccc2)cn1-c(cc1)ccc1F)=O)=O

InChI

InChI=1S/C31H32FN5O4/c1-40-27-13-7-24(8-14-27)30(39)36(16-15-35-17-19-41-20-18-35)22-29(38)34-31-33-28(23-5-3-2-4-6-23)21-37(31)26-11-9-25(32)10-12-26/h2-14,21H,15-20,22H2,1H3,(H,33,34,38)

InChI Key

CJTWHKNDHZWJRZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19820868

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

557.62

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.028

Distribution Coefficient, logD

4.024

Water Solubility, LogSw

-3.98

Polar Surface Area

71.806

Acid Dissociation Constant (pKa)

13.10

Base Dissociation Constant (pKb)

5.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.80

V020-0741 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

SH2 Library (10483 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V020-0741 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-0741?
Check Price and Availability of V020-0741, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-0741 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-0741
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-0741
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-0741 available by request